Document Detail


Effects of whey peptides on cardiovascular disease risk factors.
MedLine Citation:
PMID:  17086017     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Previous studies have shown that peptides derived from milk proteins can improve blood pressure. Therefore, the authors tested the blood pressure-lowering effects of a hydrolyzed whey protein supplement rich in bioactive peptides. In a 6-week controlled study, 30 prehypertensive or stage 1 hypertensive subjects (blood pressure >or=120/80 mm Hg and <or=155/95 mm Hg) were randomized to receive 20 g/d of either a hydrolyzed whey protein (active treatment) or an unmodified whey protein (control treatment). Blood pressure, blood lipids, safety measures, side effects, and diet were evaluated throughout the trial. After completion of treatment, a 4-week follow-up was conducted. There was a mean reduction of 8.0+/-3.2 mm Hg in systolic blood pressure (P<.05) and of 5.5+/-2.1 mm Hg in diastolic blood pressure (P<.05) in the treatment group compared with the control group. Low-density lipoprotein cholesterol and high-sensitivity C-reactive protein were significantly improved by treatment. Whey-derived peptides might be a viable treatment option for prehypertensive and/or stage 1 hypertensive populations.
Authors:
Joel J Pins; Joseph M Keenan
Related Documents :
11695137 - The prevalence of hypertension in a dental school patient population.
7662237 - Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in norm...
16945057 - Effectiveness of a two-part educational intervention to improve hypertension control: a...
10466477 - Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolate...
14729987 - Plantar pressure and joint motion after the youngswick procedure for hallux limitus.
19151287 - Short-term administration of a high oxygen concentration is not injurious in an ex-vivo...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Retracted Publication    
Journal Detail:
Title:  Journal of clinical hypertension (Greenwich, Conn.)     Volume:  8     ISSN:  1524-6175     ISO Abbreviation:  J Clin Hypertens (Greenwich)     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-11-06     Completed Date:  2007-01-30     Revised Date:  2008-09-30    
Medline Journal Info:
Nlm Unique ID:  100888554     Medline TA:  J Clin Hypertens (Greenwich)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  775-82     Citation Subset:  IM    
Affiliation:
Department of Family Medicine and Community Health, University of Minnesota Medical School, Hypertension and Cholesterol Research Center, Minneapolis, MN 5545, USA. pinsx001@umn.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Pressure / physiology
Cardiovascular Diseases / blood,  diet therapy*,  physiopathology
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Double-Blind Method
Female
Follow-Up Studies
Humans
Male
Middle Aged
Milk Proteins / therapeutic use*
Pilot Projects
Questionnaires
Treatment Outcome
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Milk Proteins; 0/Triglycerides; 0/whey protein
Comments/Corrections
Retraction In:
J Clin Hypertens (Greenwich). 2008 Aug;10(8):631   [PMID:  18780483 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Arterial elasticity and erectile dysfunction in hypertensive men.
Next Document:  Angiotensin receptor blockade improves vascular compliance in healthy normotensive elderly individua...